TechPortal: Overview

Commercial Viability in a One-Stop Shop

New businesses created by campus entrepreneurs now have a home-team advantage.

TechPortal, a business technology incubator in the Calit2 Building, serves as a gateway to commercial viability for UCI-based startup companies. TechPortal offers affordable space, access to facilities and services, and mentoring, programs and expertise to help new companies gain traction in the marketplace.

TechPortal can house up to six companies in its 1460 square feet of space and Calit2 offers the perfect combination of lab space, experts, programs and facilities. Its wet and dry lab spaces provide options for a wide range of startup companies.

Companies must be either based on or licensing UC technology, or founded by UCI faculty, staff or students, and already incorporated and able to commit to six months of rent. A database of UCI technologies available for licensing can be found here. A database of all 10 UC campus technologies can be found here.

In addition to affordable space and short-term leases, TechPortal benefits include classes, workshops, lectures, networking opportunities and one-on-one advice offered by the Merage School of Business, the Don Beall Center for Innovation and Entrepreneurship, the Office of Technology Alliances, OCTANe (which recently merged with the Orange County Venture Group, creating the largest innovation-oriented organization in the county) and the Irvine Incubation Network.

All UCI lab facilities are easily accessible and available for recharge. The Microscopy Center, the Calit2 BiON facility, the Integrated Nanosystems Research Facility (INRF), the Materials Characterization Center (MC2), the HIPerWall, and other labs and clean rooms on campus offer incubated businesses convenient access to the latest equipment and technology resources.

TechPortal companies have – in a one-stop shop – the capabilities and resources necessary to manage and succeed at the design, regulatory, manufacturing, marketing and fundraising issues they will face on their journey to commercialization.